Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 1.0M | 1.3M | 1.4M | 1.2M | 695,000 |
| Operating Revenue | 1.0M | 1.3M | 1.4M | 1.2M | 695,000 |
| Cost Of Revenue | 1.2M | 1.4M | 1.2M | 1.2M | 1.0M |
| Gross Profit | -164,000 | -110,000 | 152,000 | -28,000 | -335,000 |
| Selling General And Administration | 3.7M | 4.6M | 4.7M | 5.6M | 3.6M |
| General And Administrative Expense | 3.7M | 4.6M | 4.7M | 5.6M | 3.6M |
| Other Operating Expenses | 18.3M | 14.1M | 17.5M | 13.6M | 11.9M |
| Operating Expense | 21.9M | 18.7M | 22.3M | 19.2M | 15.4M |
| Operating Income | -22.1M | -18.8M | -22.1M | -19.3M | -15.8M |
| EBIT | -130.4M | 12.5M | -48.9M | -29.4M | -25.9M |
| Interest Expense | 5.0M | 54,000 | 680,000 | 103,000 | 0.00 |
| Interest Expense Non Operating | 5.0M | 54,000 | 680,000 | 103,000 | 0.00 |
| Interest Income | 2.8M | 941,000 | 1.3M | 1.5M | 1.9M |
| Interest Income Non Operating | 2.8M | 941,000 | 1.3M | 1.5M | 1.9M |
| Net Interest Income | -3.0M | 168,000 | 636,000 | 751,000 | 1.1M |
| Other Income Expense | -110.3M | 31.0M | -28.1M | -11.0M | -11.3M |
| Other Non Operating Income Expenses | -34,000 | 442,000 | 388,000 | 3.9M | 720,000 |
| Special Income Charges | -- | -- | 251,000 | 142,000 | 20,000 |
| Gain On Sale Of Security | -109.9M | 32.4M | -27.8M | -16.7M | -11.4M |
| Earnings From Equity Interest | -367,000 | -1.8M | -902,000 | 1.7M | -604,000 |
| Pretax Income | -135.4M | 12.4M | -49.6M | -29.5M | -25.9M |
| Tax Provision | -421,000 | -83,000 | -6.0M | 3,000 | -166,000 |
| Tax Effect Of Unusual Items | -341,708 | 4.9M | -3.3M | -2.5M | -72,902 |
| Net Income From Continuing And Discontinued Operation | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Net Income From Continuing Operation Net Minority Interest | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Net Income Including Noncontrolling Interests | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Net Income Common Stockholders | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Net Income | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| EBITDA | -124.9M | 15.2M | -46.4M | -27.0M | -23.6M |
| Normalized EBITDA | -15.0M | -17.2M | -18.8M | -10.4M | -12.2M |
| Reconciled Depreciation | 5.5M | 2.7M | 2.5M | 2.4M | 2.3M |
| Basic EPS | -0.15 | 0.01 | -0.05 | -- | -0.03 |
| Diluted EPS | -0.15 | 0.01 | -0.05 | -- | -0.03 |
| Basic Average Shares | 896.6M | 896.3M | 895.8M | -- | 892.5M |
| Diluted Average Shares | 896.6M | 903.2M | 895.8M | -- | 892.5M |
| Total Unusual Items | -109.9M | 32.4M | -27.5M | -16.6M | -11.4M |
| Total Unusual Items Excluding Goodwill | -109.9M | 32.4M | -27.5M | -16.6M | -11.4M |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.12 | 0.15 | 0.01 |
| Normalized Income | -25.4M | -15.0M | -19.3M | -15.4M | -14.5M |
| Diluted NI Availto Com Stockholders | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Gain On Sale Of Business | -- | -- | 251,000 | -- | -- |
| Gain On Sale Of Ppe | -- | -- | -- | 142,000 | 20,000 |
| Net Income Continuous Operations | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Net Income Discontinuous Operations | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Net Non Operating Interest Income Expense | -3.0M | 168,000 | 636,000 | 751,000 | 1.1M |
| Other Gand A | 3.7M | 4.6M | 4.7M | 5.6M | 3.6M |
| Reconciled Cost Of Revenue | 1.2M | 1.4M | 1.2M | 1.2M | 1.0M |
| Total Expenses | 23.1M | 20.1M | 23.5M | 20.4M | 16.5M |
| Total Other Finance Cost | 772,000 | 719,000 | -- | 692,000 | 776,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 471.3M | 54.5M | 83.6M | 108.5M | 105.9M |
| Cash Cash Equivalents And Short Term Investments | 482.8M | 94.2M | 90.7M | 114.8M | 116.4M |
| Cash Equivalents | 466.4M | 49.7M | 80.0M | 104.4M | 104.1M |
| Cash Financial | 4.8M | 4.8M | 3.6M | 4.1M | 1.8M |
| Other Short Term Investments | 11.5M | 39.7M | 7.1M | 6.3M | 10.5M |
| Accounts Receivable | 7.2M | 4.1M | 3.8M | 3.1M | 3.4M |
| Receivables | 7.2M | 4.1M | 3.8M | 3.1M | 3.4M |
| Inventory | 8.0M | 4.1M | 3.8M | 3.7M | 3.6M |
| Other Current Assets | 2.0M | 3.0M | 2.5M | 2.1M | 816,000 |
| Current Assets | 499.9M | 105.4M | 100.8M | 123.7M | 124.2M |
| Gross PPE | 329.2M | 311.3M | 305.0M | 302.7M | 300.9M |
| Accumulated Depreciation | -48.6M | -45.9M | -44.4M | -43.1M | -42.5M |
| Net PPE | 280.6M | 265.4M | 260.6M | 259.7M | 258.4M |
| Investments And Advances | 254.9M | 240.8M | 241.4M | 266.5M | 275.4M |
| Long Term Equity Investment | 19.5M | 19.7M | 20.2M | 20.7M | 18.2M |
| Other Investments | 216.9M | 203.5M | 203.8M | 231.1M | 242.8M |
| Other Non Current Assets | 15.1M | 15.3M | 15.7M | 13.7M | 13.9M |
| Total Non Current Assets | 607.3M | 521.5M | 517.6M | 539.9M | 547.6M |
| Total Assets | 1.1B | 626.9M | 618.4M | 663.6M | 671.9M |
| Accounts Payable | 23.6M | 9.9M | 15.9M | 13.3M | 6.6M |
| Payables | 32.9M | 20.1M | 24.8M | 21.3M | 12.9M |
| Payables And Accrued Expenses | 35.5M | 20.1M | 24.8M | 21.3M | 12.9M |
| Current Accrued Expenses | 2.5M | -- | -- | -- | -- |
| Current Deferred Revenue | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M |
| Other Current Liabilities | 630,000 | 567,000 | 484,000 | 6.3M | 120,000 |
| Current Liabilities | 41.8M | 26.7M | 31.4M | 33.9M | 19.8M |
| Long Term Debt | 294.8M | -- | -- | -- | -- |
| Long Term Debt And Capital Lease Obligation | 294.8M | -- | -- | -- | -- |
| Other Non Current Liabilities | 2.7M | 2.8M | 2.9M | 2.9M | 3.0M |
| Total Non Current Liabilities Net Minority Interest | 662.5M | 64.3M | 64.8M | 65.4M | 67.2M |
| Total Liabilities Net Minority Interest | 704.3M | 91.0M | 96.2M | 99.3M | 87.0M |
| Common Stock | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B |
| Capital Stock | 1.7B | 1.7B | 1.7B | 1.7B | 1.7B |
| Additional Paid In Capital | 75.2M | 74.8M | 73.9M | 73.3M | 72.2M |
| Retained Earnings | -1.3B | -1.2B | -1.2B | -1.2B | -1.1B |
| Gains Losses Not Affecting Retained Earnings | 1.7M | 1.6M | 1.8M | 1.8M | 1.8M |
| Other Equity Adjustments | 1.7M | 1.6M | 1.8M | 1.8M | 1.8M |
| Common Stock Equity | 402.9M | 535.9M | 522.2M | 564.3M | 584.9M |
| Stockholders Equity | 402.9M | 535.9M | 522.2M | 564.3M | 584.9M |
| Total Equity Gross Minority Interest | 402.9M | 535.9M | 522.2M | 564.3M | 584.9M |
| Total Capitalization | 697.7M | 535.9M | 522.2M | 564.3M | 584.9M |
| Net Tangible Assets | 402.9M | 535.9M | 522.2M | 564.3M | 584.9M |
| Tangible Book Value | 402.9M | 535.9M | 522.2M | 564.3M | 584.9M |
| Working Capital | 458.2M | 78.7M | 69.4M | 89.8M | 104.4M |
| Invested Capital | 697.7M | 535.9M | 522.2M | 564.3M | 584.9M |
| Total Debt | 294.8M | -- | -- | -- | -- |
| Share Issued | 897.2M | 896.4M | 896.2M | 895.7M | 892.6M |
| Ordinary Shares Number | 897.2M | 896.4M | 896.2M | 895.7M | 892.6M |
| Available For Sale Securities | 5.9M | 5.1M | 5.2M | 1.8M | -- |
| Current Deferred Liabilities | 4.5M | 4.5M | 4.5M | 4.5M | 4.5M |
| Current Provisions | 1.1M | 1.6M | 1.6M | 1.7M | 2.3M |
| Derivative Product Liabilities | 303.7M | -- | -- | -- | -- |
| Dueto Related Parties Current | 8.3M | 8.2M | 7.3M | 7.0M | 5.7M |
| Financial Assets | 56.7M | -- | -- | -- | -- |
| Held To Maturity Securities | 12.6M | 12.5M | 12.2M | 13.0M | 14.4M |
| Interest Payable | 2.5M | -- | -- | -- | -- |
| Investmentin Financial Assets | 18.5M | 17.6M | 17.4M | 14.8M | 14.4M |
| Investmentsin Joint Venturesat Cost | 19.5M | 19.7M | 20.2M | 20.7M | 18.2M |
| Long Term Provisions | 31.7M | 31.1M | 30.9M | 30.6M | 31.9M |
| Machinery Furniture Equipment | 144.0M | 126.8M | 124.1M | 118.6M | 115.5M |
| Non Current Deferred Liabilities | 29.6M | 30.3M | 31.0M | 31.9M | 32.3M |
| Non Current Deferred Revenue | 27.9M | 28.2M | 28.8M | 29.5M | 29.9M |
| Non Current Deferred Taxes Liabilities | 1.7M | 2.1M | 2.2M | 2.4M | 2.4M |
| Other Payable | 1.0M | 1.9M | 1.6M | 1.0M | 619,000 |
| Other Properties | 2.2M | 2.2M | -- | -- | 2.5M |
| Raw Materials | 8.0M | -- | -- | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -19.9M | -23.0M | -16.9M | -8.0M | -12.4M |
| Cash Flow From Continuing Operating Activities | -19.9M | -23.0M | -16.9M | -8.0M | -12.4M |
| Depreciation Amortization Depletion | 5.5M | 2.7M | 2.5M | 2.4M | 2.3M |
| Stock Based Compensation | 1.1M | 1.1M | 1.4M | 1.2M | 1.2M |
| Deferred Tax | -421,000 | -83,000 | -6.0M | 3,000 | -166,000 |
| Deferred Income Tax | -421,000 | -83,000 | -6.0M | 3,000 | -166,000 |
| Change In Working Capital | 13,000 | -6.8M | 2.2M | 6.5M | -326,000 |
| Change In Receivables | -3.2M | -429,000 | -834,000 | 551,000 | -865,000 |
| Change In Inventory | -2.9M | -333,000 | -23,000 | -102,000 | -438,000 |
| Change In Payables And Accrued Expense | 5.1M | -5.6M | 3.1M | 7.4M | 529,000 |
| Other Non Cash Items | 34.6M | -1.7M | -1.7M | -3.4M | -1.6M |
| Capital Expenditure | -7.8M | -5.2M | -6.1M | -2.5M | -2.1M |
| Purchase Of PPE | -7.8M | -5.2M | -6.1M | -2.5M | -2.1M |
| Net PPE Purchase And Sale | -7.8M | -5.2M | -6.1M | -2.5M | -2.1M |
| Purchase Of Business | -1.1M | 0.00 | -632,000 | -2.7M | -666,000 |
| Sale Of Investment | 31.2M | -- | -- | 0.00 | 0.00 |
| Net Investment Purchase And Sale | -17.7M | -- | -- | 0.00 | 0.00 |
| Investing Cash Flow | -26.3M | -4.8M | -7.7M | -5.0M | -2.5M |
| Cash Flow From Continuing Investing Activities | -26.3M | -4.8M | -7.7M | -5.0M | -2.5M |
| Repayment Of Debt | -117,000 | -134,000 | -108,000 | -88,000 | -94,000 |
| Net Issuance Payments Of Debt | 458.9M | -134,000 | -108,000 | -88,000 | -94,000 |
| Issuance Of Capital Stock | -- | -- | -- | 14.1M | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | 14.1M | 0.00 |
| Financing Cash Flow | 459.9M | 2,000 | -331,000 | 14.1M | 82,000 |
| Cash Flow From Continuing Financing Activities | 459.9M | 2,000 | -331,000 | 14.1M | 82,000 |
| Effect Of Exchange Rate Changes | 3.0M | -1.3M | -20,000 | 1.5M | -292,000 |
| Changes In Cash | 413.7M | -27.7M | -24.9M | 1.1M | -14.8M |
| Beginning Cash Position | 54.5M | 83.6M | 108.5M | 105.9M | 121.1M |
| End Cash Position | 471.3M | 54.5M | 83.6M | 108.5M | 105.9M |
| Free Cash Flow | -27.6M | -28.2M | -23.0M | -10.5M | -14.5M |
| Change In Prepaid Assets | 1.0M | -451,000 | 23,000 | -1.3M | 448,000 |
| Common Stock Issuance | -- | -- | -- | 14.1M | 0.00 |
| Depletion | 5.5M | 2.7M | 2.5M | -- | 2.3M |
| Earnings Losses From Equity Investments | 243,000 | 426,000 | 511,000 | -1.7M | 604,000 |
| Gain Loss On Sale Of Business | -- | -- | 140,000 | -- | -- |
| Gain Loss On Sale Of PPE | 0.00 | 0.00 | 0.00 | -13,000 | -19,000 |
| Long Term Debt Payments | -117,000 | -134,000 | -108,000 | -88,000 | -94,000 |
| Net Business Purchase And Sale | -1.1M | 0.00 | -632,000 | -2.7M | -666,000 |
| Net Foreign Currency Exchange Gain Loss | -530,000 | 1.1M | 17,000 | -1.5M | 308,000 |
| Net Income From Continuing Operations | -135.0M | 12.5M | -43.5M | -29.5M | -25.8M |
| Net Long Term Debt Issuance | 458.9M | -134,000 | -108,000 | -88,000 | -94,000 |
| Net Other Financing Charges | 0.00 | 0.00 | -252,000 | -- | -- |
| Net Other Investing Changes | 189,000 | 475,000 | -996,000 | 175,000 | 262,000 |
| Operating Gains Losses | 90.4M | 1.4M | 668,000 | -3.2M | 893,000 |
| Proceeds From Stock Option Exercised | 987,000 | 136,000 | 29,000 | 115,000 | 176,000 |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 13,000 | 20,000 |
| Unrealized Gain Loss On Investment Securities | -16.2M | -32.2M | 27.5M | 17.9M | 11.1M |